by Christine Stackhouse | Jul 8, 2025
On July 2, 2025, the federal government announced the formation of a new False Claims Act (FCA) enforcement task force aimed at the pharmaceutical, medical device, and health care industries. Attorneys from the Department of Health and Human Services (HHS) and the...
by Mallory Schowe | Jul 8, 2025
On July 4, 2025, President Trump signed the One Big Beautiful Bill Act (OBBBA) into law. The OBBBA makes permanent several provisions implemented by Trump’s 2017 Tax Cuts and Jobs Act (TCJA) and also introduces several new rules, many which significantly affect...
by Christine Stackhouse | Jul 7, 2025
The Federal Trade Commission’s (“FTC”) recent settlement of the Synopsys/Ansys merger and the Department of Justice Antitrust Division’s (“DOJ”) settlement of the Keysight/Spirent merger are signs that, under the new Trump administration, the agencies are interested...
by Christine Stackhouse | Jul 1, 2025
Inventions claimed in a patent must meet a threshold subject matter eligibility (SME) requirement imposed by the U.S. patent laws.[1] The Supreme Court’s two-step Alice test provides a framework for analyzing whether a claimed invention passes the SME threshold.[2] If...
by Christine Stackhouse | Jun 30, 2025
On June 23, 2025, U.S. District Judge Alsup of the Northern District of California issued a decision in the high-profile lawsuit brought by several authors against Anthropic, the AI developer of the Claude chatbot. The authors accused Anthropic of copyright...
